References
- Pinel C, Fricker-Hidalgo H, Lebeau B, Garban F, Hamidfar R, Ambroise-Thomas P, Grillot R. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 2003;41:2184–6.
- Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and haemopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7–14.
- Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 1992;86:243–8.
- Kahn FW, Jones JM, England DM. The role of bronchoal-veolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986;86:518–23.
- Park GR, Drummond GB, Lamb D, Durie TB, Milne LJ, Lambie AT, Cameron EW. Disseminated aspergillosis occurring in patients with respiratory, renal, and hepatic failure. Lancet 1982;2:179–83.
- Walsh TJ, Hamilton SR. Disseminated aspergillosis complicating hepatic failure. Arch Intern Med 1983;143:1189–91.
- Singh N, Arnow PM, Bonham A, Dominguez E, Paterson DL, Pankey GA, et al. Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation 1997;64:716–20.
- Manavathu EK, Ganesan LT, Cutright JL, Chandrasekar PH. In vitro antifungal activity of voriconazole in 2-drug combination with micafungin, caspofungin, and amphotericin B [abstract J-125]. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2001.
- Kirkpatrick WR, Perea S, Coco BJ, Patterson T. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother 2002;46:2564–8.
- Steinbach WJ, Stevens DA, Denning DW. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1996 to 2001. Clin Infect Dis 2003; 37\(Suppl 3):S188–224.
- Thiébaut SR, Antal D, Breysse MC, Pivot C. Refractory invasive fungal infections in patients with haematological malignancies: combination of new antifungal agents (voriconazole or caspofungin) with amphotericin B. ICAAC 2002 [abstract M-859]. In: Program and abstracts of the 42st Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 2002.
- Gentina T, De Botton S, Alfandari S, Delomez J, Jaillard S, Leroy O, et al. Combination antifungals for treatment of pulmonary invasive aspergillosis refractory to amphotericin B in leukaemia patients. ICAAC 2002 [abstract M-860]. In: Program and abstracts of the 42st Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 2002.